CN Stock MarketDetailed Quotes

000623 Jilin Aodong Pharmaceutical Group

Watchlist
  • 15.24
  • +0.16+1.06%
Noon Break Apr 29 11:30 CST
18.23BMarket Cap12.48P/E (TTM)

About Jilin Aodong Pharmaceutical Group Company

The company's predecessor was the state-owned Yanbian Dunhua Deer Farm established in 1957. Aodong Pharmaceutical Factory was established in 1981, approved by the Jilin Provincial Economic System Reform Commission in 1993, renamed Jilin Aodong Pharmaceutical Group Co., Ltd. in 1998, and listed on the Shenzhen Stock Exchange on October 28, 1996. In 2001, Aodong, Jilin established a parent and subsidiary company system and gradually developed into a holding group listed company based on the pharmaceutical industry and rapidly developing under the “pharmaceutical+finance+big health” multi-wheel drive model. Mainly engaged in R&D, manufacturing and sales of traditional Chinese medicines and chemicals. The company's main products include “Brain Relief Solution”, “Pediatric Chai Gui Antipyretic Oral Solution”, “Brain Relief Oral Solution”, “Brain Relief Oral Solution”, “Blood Enhancing Drink Oral Solution”, “Pingyangmycin Hydrochloride for Injection”, “Muscle Extender Tablets”, “Injectable Ribonucleic Acid II”, “Renal Rehabilitation Tablets”, “Lingbei Cough Syrup”, “Injectable Urokinase”, “Lypirin for Injections”, “Injectable Lysiline for Injections” “Liquid”, “cold relief capsules”, etc. Corporate honors: National Technological Innovation Demonstration Enterprise, National Intellectual Property Advantage Enterprise, National Accredited Enterprise Technology Center, etc. It has successively won the National Torch Program's Key High-tech Enterprise, National Innovative Enterprise, National Model Labor Relations Harmonious Enterprise, National Model Labor Relations Enterprise, National May 1st Labor Award, National Advanced Unit for Open and Democratic Factory Management, National Leading Agricultural Industrialization Enterprise, National Non-public Enterprise “Double Top 100” Party Organization, National Industrial Enterprise Quality Benchmark, 16th and 21st National Enterprise Management Modernization Innovation Achievements Award. Over the years, it has been rated as an A-level taxpayer and an AAA “contract-abiding and credit-worthy” unit. It has won many honors such as a national new product, the second prize for scientific and technological progress in Jilin Province, and a national protected variety of traditional Chinese medicine.

Company Profile

Short Name-A吉林敖东
Symbol-A000623
Company NameJiLin AoDong Medicine Industry Croups Co.,ltd
Listing DateOct 28, 1996
Issue Price7.20
Shares Offered18.00M share(s)
FoundedMar 20, 1993
Listed ExchangeSZ Stock Exchange
Legal Representativexiulin li
CEOshuqin guo
Secretaryzhenyu wang
Accounting FirmZhongzhu Certified Public Accountants (Special General Partnership)
Securities Representativerenhe zhao
Legal CounselBeijing Kyoto (Dalian) Law Firm
Employees33
Phone0433-6238973
Office AddressNo. 2158, Aodong Street, Dunhua City, Jilin Province
Zip Code133700
Registered AddressNo. 2158, Aodong Street, Dunhua City, Yanbian Korean Autonomous Prefecture, Jilin Province
Fax0433-6238973
Email000623@jlaod.com
Business License220000000072468
BusinessFarming, breeding, and commerce (excluding special state control and franchising); machinery repair and storage; import of raw and auxiliary materials, mechanical equipment, instruments, and spare parts required for the production and research of the enterprise (excluding 12 types of imported goods operated by authorized companies by the state); pharmaceutical industry, pharmaceutical business, pharmaceutical research and development; car rental services; own real estate business activities. (For projects that require approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • xiulin li
  • Chairman,directors
  • 3.21M
  • shuqin guo
  • Vice Chairman,directors,general manager,Director of the Strategy Committee
  • 2.61M
  • shuyuan zhang
  • directors,Deputy General Manager,Chief Financial Officer,Member of the Investment Committee,Remuneration and Assessment Committee Members
  • 785.10K
  • kai yang
  • directors,Deputy General Manager,Director of the Investment Committee,Audit Committee Members
  • 805.10K
  • zhenyu wang
  • directors,Board Secretary,Deputy General Manager,Member of the Investment Committee,Nomination Committee Members
  • 735.10K
  • dalong zhao
  • directors,Strategy Committee Members
  • 735.10K
  • peng li
  • Independent directors,Director of the Nomination Committee,Remuneration and Assessment Committee Members
  • 132.50K
  • biming liang
  • Independent directors,Audit Committee Director,Nomination Committee Members
  • 60.00K
  • weiwei xiao
  • Independent directors,Audit Committee Members,Director of the Remuneration and Assessment Committee,Strategy Committee Members
  • 132.50K
  • renhe zhao
  • Securities affairs representative
  • --
  • yongfeng chen
  • Supervisory Director,auditors
  • 425.10K
  • gang xiu
  • auditors
  • 27.50K
  • yuju sun
  • auditors
  • 27.50K
  • xiaolin lin
  • Deputy General Manager
  • 335.10K
  • mingjing zhang
  • Employee supervisors
  • 138.50K
  • anning li
  • Employee supervisors
  • 27.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg